Patients with Gaucher disease do not appear to be at increased risk for SARS-CoV-2 infection, according to findings presented at the 17th Annual WORLDSymposium.
Results from an in vitro study suggest that antibodies elicited from the Pfizer-BioNTech COVID-19 vaccine can effectively neutralize SARS-CoV-2 with the mutation...